Discovery of the Novel Entecavir‐Resistant Hepatitis B Virus Reverse Transcriptase A181C Substitution From an Integrated Genotypic Analysis

por Rose, Ronald E., Hernandez, Dennis, Falk, Paul J., Ericson, Karen, Zhou, Nannan, Thiry, Alexandra, McPhee, Fiona
Publicado 2018

Clinical evidence for a lack of cross-resistance between temsavir and ibalizumab or maraviroc

por Rose, Ronald, Gartland, Margaret, Li, Zhufang, Zhou, Nannan, Cockett, Mark, Beloor, Jagadish, Lataillade, Max, Ackerman, Peter, Krystal, Mark
Publicado 2022

A Novel Small Molecule Inhibitor of Hepatitis C Virus Entry

por Baldick, Carl J., Wichroski, Michael J., Pendri, Annapurna, Walsh, Ann W., Fang, Jie, Mazzucco, Charles E., Pokornowski, Kevin A., Rose, Ronald E., Eggers, Betsy J., Hsu, Mayla, Zhai, Weixu, Zhai, Guangzhi, Gerritz, Samuel W., Poss, Michael A., Meanwell, Nicholas A., Cockett, Mark I., Tenney, Daniel J.
Publicado 2010

High-Throughput Screening and Rapid Inhibitor Triage Using an Infectious Chimeric Hepatitis C Virus

por Wichroski, Michael J., Fang, Jie, Eggers, Betsy J., Rose, Ronald E., Mazzucco, Charles E., Pokornowski, Kevin A., Baldick, Carl J., Anthony, Monique N., Dowling, Craig J., Barber, Lauren E., Leet, John E., Beno, Brett R., Gerritz, Samuel W., Agler, Michele L., Cockett, Mark I., Tenney, Daniel J.
Publicado 2012